Отправить статью по E-mail Studying of the Mechanisms of Combined Effect of Dexamethasone, Doxorubicin, and Docetaxel on Breast Cancer Cells
- Авторы: Dukhanina E.A.1, Portseva T.N.1,2, Dukhanin A.S.2, Georgieva S.G.1
-
Учреждения:
- V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences
- N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
- Выпуск: Том 166, № 1 (2018)
- Страницы: 54-57
- Раздел: Article
- URL: https://ogarev-online.ru/0007-4888/article/view/240828
- DOI: https://doi.org/10.1007/s10517-018-4288-2
- ID: 240828
Цитировать
Открытый доступ
Доступ предоставлен
Только для подписчиков
Аннотация
The sensitivity of MDA-MB231 breast cancer cells to the effects of pharmacological agents was evaluated by their motility and viability. Dexamethasone, doxorubicin, or docetaxel administered separately in their effective concentration suppressed cell motility (in 16 h) and caused cell death (in 48 h). The strength of the effects increased in the following order: dexa methasone
Об авторах
E. Dukhanina
V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences
Автор, ответственный за переписку.
Email: das03@rambler.ru
Россия, Moscow
T. Portseva
V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences; N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
Email: das03@rambler.ru
Россия, Moscow; Moscow
A. Dukhanin
N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
Email: das03@rambler.ru
Россия, Moscow
S. Georgieva
V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences
Email: das03@rambler.ru
Россия, Moscow
Дополнительные файлы
